Industry Intelligence
Despite price cuts and government programs, out-of-pocket GLP-1 costs remain prohibitive for most patients. New data reveals a fundamental affordability
Read More
January 2026 survey findings highlight systemic blind spot in pharmaceutical distribution. Only 20% of hospital pharmacies report full, real-time visibility
Read More
August 28, 2026 — BioNTech and Genentech terminated the Phase 2 trial of autogene cevumeran (BNT122) in resected colorectal cancer
Read More
The FDA approved Mimrylo (rusfertide), a first-in-class hepcidin-mimicking therapy that fundamentally changes how polycythemia vera is managed, offering 76.9% of
Read More
The FDA cleared tirzepatide (Mounjaro) to reduce cardiovascular death, heart attacks, and strokes in type 2 diabetes patients—marking a watershed
Read More
PHSE Group acquires L.S. Logistica Sanitaria to integrate hospital logistics with pharmaceutical cold-chain distribution across Italy’s €25B healthcare system. How
Read More
A personalized mRNA cancer vaccine beat Keytruda alone in a Phase 3 trial, slashing melanoma recurrence risk by up to
Read More
Definium’s DT120 hit its primary endpoint in a Phase 3 anxiety trial, marking the psychedelics developer’s second late-stage win in
Read More
The FDA has approved Tauklarify, a new PET imaging tracer that detects tau tangles in patients being evaluated for Alzheimer’s
Read More
Novo’s oral Wegovy has plateaued around a third of total scripts, while Lilly’s Foundayo keeps notching new weekly highs on
Read More